Conservative management of COVID-19 associated hypoxaemia
- PMID: 33738306
- PMCID: PMC7848791
- DOI: 10.1183/23120541.00026-2021
Conservative management of COVID-19 associated hypoxaemia
Abstract
Background: Invasive mechanical ventilation of hypoxaemic coronavirus disease 2019 (COVID-19) patients is associated with mortality rates of >50%. We evaluated clinical outcome data of two hospitals that agreed on a predefined protocol for restrictive use of invasive ventilation where the decision to intubate was based on the clinical presentation and oxygen content rather than on the degree of hypoxaemia.
Method: Data analysis was carried out of patients with positive PCR-testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), typical history, and symptoms and pulmonary infiltrates who exhibited oxygen saturation values of <93%.
Results: We identified 78 patients who met the inclusion criteria. The oxygen saturation nadir was 84.4±6.5% for the whole group. 53 patients (68%) received nasal oxygen (group 1), 17 patients (22%) were treated with nasal high-flow continuous positive airway pressure (CPAP), noninvasive ventilation or a combination thereof (group 2), and eight patients (10%) were intubated (group 3). The Horovitz index was 216±8 for group 1, 157±13 for group 2 and 106±15 for group 3. Oxygen content was 14.5±2.5, 13.4±1.9 and 11.6±2.6 mL O2·dL-1 for the three respective groups. Overall mortality was 7.7%; the mortality of intubated patients was 50%. Overall, 93% of patients could be discharged on room air.
Conclusion: Permissive hypoxaemia where decisions for the level of respiratory therapy were based on the clinical presentation and oxygen content resulted in low intubation rates, low overall mortality and a low number of patients who require oxygen after discharge.
Copyright ©The authors 2021.
Conflict of interest statement
Conflict of interest: T. Voshaar has nothing to disclose. Conflict of interest: P. Stais has nothing to disclose. Conflict of interest: D. Köhler has nothing to disclose. Conflict of interest: D. Dellweg has nothing to disclose.
Figures






Similar articles
-
Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial.Lancet Respir Med. 2019 Apr;7(4):303-312. doi: 10.1016/S2213-2600(19)30048-7. Epub 2019 Mar 18. Lancet Respir Med. 2019. PMID: 30898520 Clinical Trial.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
New method of preoxygenation for orotracheal intubation in patients with hypoxaemic acute respiratory failure in the intensive care unit, non-invasive ventilation combined with apnoeic oxygenation by high flow nasal oxygen: the randomised OPTINIV study protocol.BMJ Open. 2016 Aug 12;6(8):e011298. doi: 10.1136/bmjopen-2016-011298. BMJ Open. 2016. PMID: 27519921 Free PMC article. Clinical Trial.
-
Prone positioning in non-intubated patients with COVID-19 associated acute respiratory failure, the PRO-CARF trial: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Nov 23;21(1):940. doi: 10.1186/s13063-020-04882-2. Trials. 2020. PMID: 33225990 Free PMC article. Clinical Trial.
-
Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trial.Lancet. 2015 Sep 12;386(9998):1057-65. doi: 10.1016/S0140-6736(15)60249-5. Epub 2015 Aug 19. Lancet. 2015. PMID: 26296950 Clinical Trial.
Cited by
-
Oxygen: Friend or foe in the COVID-19 battle.Clin Case Rep. 2021 Dec 26;9(12):e05254. doi: 10.1002/ccr3.5254. eCollection 2021 Dec. Clin Case Rep. 2021. PMID: 34963816 Free PMC article.
-
Analysis of an Individualised Stepwise Approach to Non-Pharmacological Therapy in COVID-19.Respiration. 2023;102(9):833-842. doi: 10.1159/000533522. Epub 2023 Sep 5. Respiration. 2023. PMID: 37669641 Free PMC article.
-
Basing intubation of acutely hypoxemic patients on physiologic principles.Ann Intensive Care. 2024 Jun 12;14(1):86. doi: 10.1186/s13613-024-01327-w. Ann Intensive Care. 2024. PMID: 38864960 Free PMC article. Review.
-
Intubation Timing in COVID-19 Based on ROX Index and Association With Patient Outcomes.Respir Care. 2022 Oct;67(10):1291-1299. doi: 10.4187/respcare.09937. Epub 2022 Mar 17. Respir Care. 2022. PMID: 35301244 Free PMC article.
References
-
- World Health Organization . Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (nCoV) Infection Is Suspected. Geneva, WHO, 2020.
-
- Luterman A, Horovitz JH, Carrico CJ, et al. . Withdrawal from positive end-expiratory pressure. Surgery 1978; 83: 328–332. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous